Q4 2024 Earnings Call Transcript March 17, 2025 FibroGen, Inc. reports earnings inline with expectations. Reported EPS is $-0 ...

Thane Wettig; Interim Chief Executive Officer, Chief Commercial Officer; FibroGen Inc. David Delucia; Vice Presi ...

The advanced validation data, 3D Epitope Mapping, is designed to enhance the efficiency and accuracy of antibody-related selection, empowering scientists with the data they need to advance their work, ...

Proteintech, a global leader in antibodies and life science solutions, is excited to announce additional product ...

Oruka Therapeutics (ORKA) announced new preclinical data on ORKA-002, a novel extended half-life monoclonal antibody targeting IL-17A/F, from ...

Half-life in non-human primates (NHP) of more than 30 days, over three times longer than bimekizumab and expected to support a dose interval of two to three times per year Equivalent potency to ...

2 lineage has been susceptible to pemivibart even if untested due to the consistent structural integrity of the pemivibart epitope. Therefore, Invivyd does not anticipate any meaningful change to ...

New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA™(pemivibart) against LP.8.1Centers for Disease Control reports LP.8.1, XEC and KP.3.1.1 together constitut ...

Methods: For designing a multi-epitope vaccine, the sequences were retrieved, and using bioinformatics and immunoinformatics, the physicochemical and immunological properties, as well as secondary ...

Add a description, image, and links to the epitope-prediction topic page so that developers can more easily learn about it.